Tianjin Key Laboratory of Neurotrauma Repair, Pingjin Hospital Brain Center, Logistics University of PAP, Tianjin, 300162, China.
The First Traditional Chinese Medicine Hospital of Luoyang City, Luoyang, 471000, China.
J Mater Sci Mater Med. 2018 Mar 19;29(4):35. doi: 10.1007/s10856-018-6033-9.
Degradation rate is an important index for evaluating biomaterials. The authors' aim was to determine whether the degradation rate of biomaterials is different in distinct tissues and to clarify the underlying mechanism of degradation. The collagen-chitosan (CG-CS) composite scaffolds were prepared using freeze-drying technology. The porosity, water absorption and swelling ratio of the scaffolds were tested in vitro. The scaffolds were implanted into the subcutis, spinal cord and brain tissues of SD rats, the rate of degradation was assessed by continuous monitoring of weight loss, the pathological changes of target areas were observed by histological staining, and matrix metalloproteinase 9 (MMP-9) and lysozyme were detected at the rapid stage of degradation of the scaffolds. Physical and chemical property testing confirmed that CG-CS composite scaffold components can meet the biological requirements of in vivo transplantation. The in vivo experimental results showed that the scaffolds were completely absorbed in the subcutis at 12 days, the scaffolds in the spinal cord and brain groups exhibited progressive mass loss starting from the 3rd week, and a substantial fraction of the scaffold was degraded at 12 weeks. HE staining found that compared with the spinal cord and brain groups, macrophages and capillaries appeared earlier in the subcutis group, and the number was significantly higher (P < 0.05). Western blot analysis showed that the MMP-9 and lysozyme levels in the subcutis were higher than those in the spinal cord and brain (P < 0.05). The results of in vivo experiments demonstrated that the CG-CS scaffold has good biocompatibility and biodegradability, while the rate of degradation was significantly different between the three tissues at the same time point. Macrophage behavior and vascularization in different parts of the body may result in control over the balance of degradation and reconstruction.
降解速率是评价生物材料的重要指标。作者旨在确定生物材料在不同组织中的降解速率是否不同,并阐明降解的潜在机制。采用冷冻干燥技术制备了胶原-壳聚糖(CG-CS)复合支架。体外测试了支架的孔隙率、吸水率和溶胀率。将支架植入 SD 大鼠的皮下、脊髓和脑组织中,通过连续监测重量损失来评估降解速率,通过组织学染色观察目标区域的病理变化,在支架快速降解阶段检测基质金属蛋白酶 9(MMP-9)和溶菌酶。理化性能测试证实 CG-CS 复合支架成分能够满足体内移植的生物学要求。体内实验结果表明,支架在皮下 12 天完全吸收,脊髓和脑组支架从第 3 周开始出现渐进性质量损失,12 周时支架大量降解。HE 染色发现,与脊髓和脑组相比,皮下组巨噬细胞和毛细血管出现更早,数量明显更高(P<0.05)。Western blot 分析显示,皮下组 MMP-9 和溶菌酶水平高于脊髓和脑组(P<0.05)。体内实验结果表明,CG-CS 支架具有良好的生物相容性和可降解性,同时在同一时间点三种组织的降解速率存在显著差异。不同部位的巨噬细胞行为和血管化可能导致降解和重建平衡的控制。